Nymox Pharmaceutical Corp
NYMXF- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001018735
No open-market purchases or sales by Nymox Pharmaceutical Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.21K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Nymox Pharmaceutical Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 5
- −30 vs. Q2 2023
- Shares held
- 130.2K
- −1.38M (−91.4%) vs. Q2 2023
- Total value
- $68.3K
- −$218.2K (−76.2%) vs. Q2 2023
- New holders
- 1
- 0 more added
- Sold out
- 31
- 0 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYMXF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4.21K |
| Q1 2026 | 1 | $2.46K |
| Q4 2025 | 1 | $1.41K |
| Q3 2025 | 1 | $2.06K |
| Q2 2025 | 1 | $4.13K |
| Q1 2025 | 2 | $16.0K |
| Q4 2024 | 1 | $3.51K |
| Q3 2024 | 2 | $13.2K |
| Q2 2024 | 1 | $6.67K |
| Q1 2024 | 3 | $48.0K |
| Q4 2023 | 2 | $26.6K |
| Q3 2023 | 5 | $68.3K |
| Q2 2023 | 36 | $287.4K |
| Q1 2023 | 35 | $575.1K |
| Q4 2022 | 37 | $443.7K |
| Q3 2022 | 34 | $494.6K |
| Q2 2022 | 39 | $590.1K |
| Q1 2022 | 40 | $2.25M |
| Q4 2021 | 43 | $2.05M |
| Q3 2021 | 38 | $4.00M |
| Q2 2021 | 51 | $4.03M |
| Q1 2021 | 59 | $13.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Nymox Pharmaceutical Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DF Dent & Co Inc | 75,000 | $39.4K | 0.00% | 00.0% | Unchanged |
| First Citizens Financial Corp | 35,100 | $18.4K | 0.01% | 00.0% | Unchanged |
| Cubic Asset Management, LLC | 10,000 | $5.25K | 0.00% | 00.0% | Unchanged |
| One Day In July LLC | 10,000 | $5.25K | 0.00% | 00.0% | Unchanged |
| Steward Financial Group LLC | 100 | $0 | 0.00% | +100 | New |
| Corrigan Financial, Inc. | 0 | $0 | 0.00% | −302,252−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −201,000−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −118,900−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −98,686−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −60,800−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −50,678−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −41,914−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −38,689−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −34,530−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −28,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −25,040−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −24,400−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −22,084−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,377−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −20,400−100.0% | Sold out |
| WMS Partners, LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −17,200−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,737−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −11,532−100.0% | Sold out |
| Lincoln National Corp | 0 | $0 | 0.00% | −11,215−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −10,219−100.0% | Sold out |
| Great Valley Advisor Group, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −5,307−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −3,296−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,005−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −859−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −708−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,430−100.0% | Sold out |
| BDO Wealth Advisors, LLC | – | – | – | – | Not filed |